Food/Warning Letter·FDA Warning Letters

Warning Letter — Nupack Inc.: Human Foods Program

MediumPublished Apr 28, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

The FDA issued a Warning Letter to Nupack Inc. following an evaluation of their compliance within the Human Foods Program.

Who it affects

This notice affects Nupack Inc., specifically their compliance and quality assurance personnel responsible for adhering to FDA food safety regulations.

Why it matters

The issuance of a Warning Letter indicates that the FDA identified significant violations of regulatory requirements during its oversight activities. While the specific nature of the violations is not detailed in the available excerpt, this action signals a formal enforcement step that could lead to further regulatory action if deviations are not addressed. It highlights the agency's continued focus on oversight within the Human Foods Program.

Practical takeaway

Quality and Regulatory leadership should review their food safety plans and verification procedures. Ensure all compliance documentation for the Human Foods Program is current and reflects actual facility practices prior to any potential federal inspections.

FDA source material

FDA issued a Warning Letter to Nupack Inc.. Subject: Human Foods Program. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nupack-inc-722113-03202026

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.